Key Details
Price
$3.38Annual ROE
-59.99%Beta
-Events Calendar
Next earnings date:
Mar 12, 2025Recent quarterly earnings:
Nov 6, 2024Recent annual earnings:
Feb 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 4, 2010Analyst ratings
Recent major analysts updates
Jan 21, 25 HC Wainwright & Co.
BuyNov 20, 24 Chardan Capital
BuyNov 18, 24 HC Wainwright & Co.
BuyNov 7, 24 HC Wainwright & Co.
BuyNov 7, 24 Chardan Capital
BuySep 5, 24 Jefferies
BuyAug 2, 24 JMP Securities
Market OutperformJun 7, 24 HC Wainwright & Co.
BuyJun 6, 24 HC Wainwright & Co.
BuyJun 5, 24 Chardan Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Arbutus Biopharma doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Arbutus Biopharma?
- Does Arbutus Biopharma pay dividends?
- What sector is Arbutus Biopharma in?
- What industry is Arbutus Biopharma in?
- What country is Arbutus Biopharma based in?
- When did Arbutus Biopharma go public?
- Is Arbutus Biopharma in the S&P 500?
- Is Arbutus Biopharma in the NASDAQ 100?
- Is Arbutus Biopharma in the Dow Jones?
- When was Arbutus Biopharma's last earnings report?
- When does Arbutus Biopharma report earnings?
- Should I buy Arbutus Biopharma stock now?
What is the ticker symbol for Arbutus Biopharma?
The ticker symbol for Arbutus Biopharma is NASDAQ:ABUS
Does Arbutus Biopharma pay dividends?
No, Arbutus Biopharma does not pay dividends
What sector is Arbutus Biopharma in?
Arbutus Biopharma is in the Healthcare sector
What industry is Arbutus Biopharma in?
Arbutus Biopharma is in the Biotechnology industry
What country is Arbutus Biopharma based in?
Arbutus Biopharma is headquartered in United States
When did Arbutus Biopharma go public?
Arbutus Biopharma's initial public offering (IPO) was on July 26, 2007
Is Arbutus Biopharma in the S&P 500?
No, Arbutus Biopharma is not included in the S&P 500 index
Is Arbutus Biopharma in the NASDAQ 100?
No, Arbutus Biopharma is not included in the NASDAQ 100 index
Is Arbutus Biopharma in the Dow Jones?
No, Arbutus Biopharma is not included in the Dow Jones index
When was Arbutus Biopharma's last earnings report?
Arbutus Biopharma's most recent earnings report was on Nov 6, 2024
When does Arbutus Biopharma report earnings?
The next expected earnings date for Arbutus Biopharma is Mar 12, 2025
Should I buy Arbutus Biopharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions